Oral Presentation 8th Australasian Vaccines & Immunotherapeutics Development Meeting 2020

Phase I clinical trial using gene-modified T cells within an academic setting (#12)

Siok Tey 1
  1. Department of Haematology and Bone Marrow Transplantation, Royal Brisbane and Women’s Hospital, Medical Director, Q-Gen Cell Therapeutics,, QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia

tbc